Bacteria-derived human leukocyte interferon (IFN) subtypes, IFN-aA, -aB, and -aD, and two hybrid IFNs, IFN-aAD and -aDA, were examined for both in vitro and in vivo antiviral activity. Two of these materials in highly purified form (IFN-aD and -aAD) protect mice against lethal doses of encephalomyocarditis virus infection. A single dose of 1 ptg of protein of IFN-aAD 3 h before infection conferred protection in both BDF1 and CD-1 mice against encephalomyocarditis virus infection, and multiple treatments with IFN-aD or IFN-aAD extend the mean survival time of infected mice. On a weight basis, IFN-aAD was approximately 100-fold more effective than IFN-aD. There is a direct correlation between the antiviral activity of the various human IFN species in L-929 cells and in mice for both single and multiple treatments before infection, but none of the cloned human IFN subtypes were effective when administered 24 h after infection. Mixtures of the two parental materials, IFN-aA and -aD, were not as protective as the hybrid molecule IFN-aAD, suggesting that IFNs with unique and altered species specificity can be produced by recombinant DNA methods.
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The recent cloning and expression of human leukocyte interferon (Hu IFN-a) genes in bacterial systems (2, 3, 9, 10) 13, 14) . For these reasons, we examined the antiviral effects of various bacteria-derived Hu IFNs against encephalomyocarditis (EMC) virus infection of mice.
The IFNs used in these experiments were produced by direct expression in Escherichia coli in a plasmid construction with the trp system (2, 3) and consisted of 165 or 166 amino acid residues. IFN-aA and IFN-aD (2) correspond to IFN-a-2 and IFN-a-1, respectively, described by Nagata et al. (9) . The presence of common restriction endonuclease sites in the gene sequences for these two IFNs has facilitated the production of four hybrid IFNs designated IFNaAD (Bgl, IFN-aAD (Pvu), IFN-aDA (Bgl), and IFN-aDA (Pvu) (Weck et al., Nucleic Acids Res., in press). However, the present in vivo studies involved only IFN-aAD (Bgo and IFNaDA (Bgl), which correspond to IFN-a-2(B)a-1 and IFN-a-l(B)a-2, respectively, of Streuli et al. (17) . We compared the ability of these two hybrid interferons to protect mice against EMC virus infection. These two hybrid IFNs, generated at the BgllI restriction enzyme site, consist of 61 amino acids from the amino terminus of IFNaA and 104 amino acids from the carboxy terminus of IFN-aD or 62 amino acids from the amino terminus of IFN-aD and 104 amino acids from the carboxy terminus of IFN-aA (Weck et al., Nucleic Acids Res., in press). They have different specific activities when assayed in mammalian cell cultures. Vesicular stomatitis virus (VSV), Indiana strain, was also purchased from ATCC and maintained by passage in BHK-21 cells. The mean titer of the virus preparation used in this study was 2.2 x 10' PFU/ml, as determined in L-929 cells. EMC virus used to infect mice was grown and stored as described previously (15) and was diluted in sterile phosphate-buffered saline (PBS) just before infection.
IFN preparation and assays. The construction and expression of bacterial plasmids containing Hu IFN genes has been described previously (2, 3) . The purification of the bacteria-derived IFNs was achieved by standard column chromatography (21) or antibody affinity columns (T. Stachlin, D. S. Hobbs, H. S. Kung, C. Y. Lai, and S. Pestka, Proc. Natl. Acad. Sci. U.S.A., in press) or both. The specific activities of the highly purified preparations of IFN-aA, -aD, -aAD, and -aDA ranged from 0.6 to 2.2 x 108 U of protein per mg when assayed on MDBK cells challenged with VSV (see Table 3 ). These IFNs were electrophoretically homogeneous and >95% pure. The biochemical properties of one of these purified IFNs has been described previously in detail (20, 21) . A comparative study was also carried out with partially purified preparations of IFN-aA, -aB, -aD, and -aAD, and these materials had specific activities of 1 x 10' U of protein per mg, as determined on MDBK cells. The mouse IFN used in these studies was a serum preparation from mice injected intraperitoneally with the double-stranded polynucleotide polyinosinic acid polycytidylic acid, from P-L Biochemicals, Inc., Milwaukee, Wis. Serum was obtained 3 h after intraperitoneal administration of 100 F±g of polyinosinic * polycytidylic acid per mouse. This IFN preparation had a titer of 6,400 U/ml, as determined on mouse L-929 cells challenged with VSV.
IFN titers were determined in a cytopathic effect inhibition assay performed in 96-well microtiter plates as described previously (1) . The NIH standard for Hu IFN (G-023-901-527) or mouse IFN (G002-904-511) was used in these assays, and all titers are in international units.
Statistical methods. The survival time of mice was obtained from records prepared twice daily for at least 21 days after infection. For convenience of presentation, deaths occurring on any 1 day are shown at one time only on the mortality curves (Fig. 1) . The average survival time for a group of mice was determined by calculating the mean of the reciprocals of the survival times (in hours) as described previously (14) and taking the reciprocal of this value. These harmonic mean survival (HMS) times account for surviving mice and indicate the relative efficacy of different treatments. Significant differences in the survival times of different groups of mice were determined by calculating logrank x2 values and accounting for surviving mice by the method of Peto and Pike (12) . The significance levels of these x2 values, which have one degree offreedom, are indicated where applicable, and 
RESULTS
Comparison of the activities of IFN-aA, -aD, -aAD, and -aDA against EMC virus infection of mice. The relative antiviral activities of highly purified (>95%) preparations of IFN-aA, -aD, -aAD, and -aDA against EMC virus infection of CD-1 mice are shown in Because the hybrid IFN-aAD is composed of 61 amino acids from the amino-terminus of IFNaA and 104 amino acids from the carboxy terminus of IFN-aD, it seems possible that a mixture of the two parental molecules could have activity similar to IFN-aAD. Comparisons of the protective effect of partially purified IFN-aAD, -aLA, -aD, and a mixture of equal units of IFNoaA and IFN-aD are shown in Figure 1 . Treatment of the mice with 10-5 U of IFN-aD resulted in significant protection (P < 0.001), whereas the same dose of IFN-aA failed to protect mice against EMC virus infection (Fig. 1, A) . Combined treatment with IFN-aA plus IFN-aD did not seem to enhance survival ( Fig. 1, B) , and this group was not significantly different from that treated with IFN-aLD alone. In contrast, doses of 104 or 105 U of IFN-aAD protected 11 of 20 and 16 of 20 mice, respectively, when given 3 h before infection (Fig. 1, C) . Table 3 show that neither IFN-oaA nor IFN-oaDA had any detectable activity against VSV infection of L-929 cells. Only IFN-aAD was consistently effective against this virus in all three cell lines, and the titers of IFNaD and IFN-aDA were approximately two and three logs higher, respectively, on bovine MDBK cells compared with WISH cells. The data in Table 3 show that equal amounts of IFNaD and -aAD, titrated on human WISH cells, cause a 68-fold difference in activity, titrated on mouse L-929 cells. Thus the difference in potency of IFN-aD and -aAD in vivo is very similar to the difference in activity in vitro. (14) . Thus, a number of cell populations that respond to exogenous IFN therapy may play a part in inhibiting EMC virus replication in infected animals. Indirect effects may be of great importance in some virus infections, such as herpes simplex type 1. Certainly, the observation that IFN-aA is not very active against herpes simplex type 1 virus in cell cultures (Weck et al., Nucleic Acids Res., in press) but reduces ocular lesions in rabbits (G. Smolin, N. Stebbing, M. Friedlaender, R. Friedlaender, and M. Okumoto, Arch. Ophthalmol., in press) suggests that indirect effects are involved with this infection in vivo. The importance of indirect effects in the rabbit system is also indicated by the efficacy of late treatments commencing 2 days after infection (Smolin et al., in press). In contrast, the purified species of IFN that we studied that are effective against EMC virus infection of mice are not effective when administered after infection, and there is a direct correlation between efficacy in murine cells and efficacy in mice. The infection of mice with EMC virus results in a viremia and seeding of target organs that eventually lead to involvement of the central nervous system (18, 19) , and this course of infection is known to be altered by IFN treatment (5, 6, 7, 11). The susceptibility to reinfection of mice surviving as a result of IFN treatment suggests that EMC virus was eliminated by IFN treatment before an adequate humoral immune response could be mounted to confer long-term protection and that IFN treatment does not act by stimulating antibody protection. Thus, direct antiviral effects may be of primary importance for EMC virus infections.
